Latest Diabetes: Type II news
Glucose-Lowering Meds Compared for Use With Metformin in T2DM
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Certain Meds Not Cost-Effective for First-Line Therapy of T2DM
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Optimizing Lifestyle Factors May Cut T2DM Risk Despite GDM History
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Reduces 10-Year Risk for T2D in Obese Persons
posted September 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors .jpg)
Recommendations Updated for Management of Anemia in CKD 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Therapies Compared for Newly Diagnosed Multiple Sclerosis Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
